Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ICI 63197

Copy Product Info
🥰Excellent
Catalog No. T22851Cas No. 27277-00-5
Alias 2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one

ICI 63197 (2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one) is a PDE4 inhibitor.

ICI 63197

ICI 63197

Copy Product Info
🥰Excellent
Purity: 99.70%
Catalog No. T22851Alias 2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-oneCas No. 27277-00-5
ICI 63197 (2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one) is a PDE4 inhibitor.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$35In StockIn Stock
50 mg$56In StockIn Stock
100 mg$77In StockIn Stock
500 mg$168In StockIn Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.70%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

ICI 63197 AI Summary
ICI 63197 shows bioactivity as an inhibitor in various assays related to different enzymes and pathways, including HSD17B4, JMJD2E, Cruzain, Cytochrome P450 2C19, ALDH1A1, Anthrax Lethal Toxin Internalization, HPGD, Cytochrome P450 2D6, Cytochrome P450 2C9, Lipid Storage Modulators, GCN5L2, Mammalian Selenoprotein Thioredoxin Reductase 1, and Arylsulfatase A. Additionally, it exhibits antiviral activity by inhibiting SARS-CoV-2 induced cytotoxicity of Caco-2 and VERO-6 cells, with inhibition rates of 6.71% and 1.48%, respectively, at a concentration of 10 µM after 48 hours. Furthermore, ICI 63197 inhibits the SARS-CoV-2 3CL-Pro protease by approximately 18.85% at a concentration of 20 µM. The compound also demonstrates inhibitory activity on the human HDAC6 enzyme, with inhibition percentages of -49.14% and -4.69% in enzymatic assays using commercial and custom peptide substrates, respectively, indicating its potential as an HDAC6 inhibitor..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
ICI 63197 (2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one) is a PDE4 inhibitor.
Targets&IC50
PDE3:9 μM (Ki), PDE1:487 μM (Ki), PDE4:10 μM (Ki), PDE2:>1000 μM (Ki)
Synonyms2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one
Chemical Properties
Molecular Weight207.23
FormulaC9H13N5O
Cas No.27277-00-5
SmilesCCCn1c2nc(N)nn2cc(C)c1=O
Relative Density.1.44 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: < 20 mg/mL, Sonication is recommended.
DMSO: < 20 mg/mL, Sonication is recommended.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy ICI 63197 | purchase ICI 63197 | ICI 63197 cost | order ICI 63197 | ICI 63197 chemical structure | ICI 63197 formula | ICI 63197 molecular weight